Bortezomib 2.5 Mg

Bortezomib 2.5 Mg Specification

Indication
Multiple myeloma, Mantle cell lymphoma

Dosage Form
Injection

Salt Composition
Bortezomib

Enzyme Types
Proteasome inhibitor

Feature
Lyophilized for reconstitution

Ingredients
Bortezomib 2.5 mg

Application
Hospital use

Physical Color/Texture
White to off-white powder

Fermentation Smell
Odorless

Enzymatic Activity
Inhibits 26S proteasome

Storage Instructions
Store below 30C

Shelf Life
2 years

Form
Injection

Injection Route
IV or SC

Packaging Type
Vial

Strength
2.5 mg

Reconstitution Required
Yes

Prescription Status
Rx Only

Bortezomib 2.5 Mg Trade Information

Minimum Order Quantity
1 Vial

Supply Ability
5000 Vials Per Month

Delivery Time
7 Days

About Bortezomib 2.5 Mg

Spotlight on the top-ranking, hot-selling Bortezomib 2.5 Mg injection-an in-demand solution for hospitals treating multiple myeloma and mantle cell lymphoma. This dominant proteasome inhibitor showcases marvelous efficacy by targeting 26S proteasome enzymatic activity. Packaged in lyophilized vials for precision reconstitution, it is exclusively available by prescription. The odorless, white to off-white powder is engineered for intravenous or subcutaneous routes, ensuring flexible and effective hospital application. As a leading exporter, supplier, trader, and wholesaler from India, we guarantee unmatched quality and reliability.

Bortezomib 2.5 Mg: Exclusively for Hospital Use

This marvelously formulated Bortezomib 2.5 Mg injection is specifically designed for use by healthcare professionals in hospital settings. Dominant in the therapeutic landscape, it is indicated for patients with multiple myeloma and mantle cell lymphoma. Only administered by trained medical staff, its powerful proteasome inhibition supports targeted cancer care. Trusted by oncologists and pharmacists throughout India and globally, this top-ranking medicine ensures optimal patient outcomes in intensive treatment environments.

Packaging Details & Express Shipping for Bortezomib 2.5 Mg

Experience secure arrival and reliable express shipping for every Bortezomib 2.5 Mg order. Each vial is lyophilized for safe reconstitution, ensuring integrity during transit. Sample availability is provided upon request, making evaluation convenient for procurement teams. Quotations are promptly issued for bulk requirements, with expedited delivery times guaranteed to hospitals and distributors. Trust our expert logistics to deliver your life-saving medication swiftly, maintaining potency and compliance from warehouse to bedside.

FAQ's of Bortezomib 2.5 Mg:

Q: How should Bortezomib 2.5 Mg be administered in a clinical setting?

A: Bortezomib 2.5 Mg is administered by intravenous (IV) or subcutaneous (SC) injection. It must be reconstituted with a suitable diluent as instructed in the product guidelines and given by a trained healthcare professional in a hospital environment.

Q: What are the primary indications for using Bortezomib 2.5 Mg?

A: This medicine is predominantly indicated for the treatment of multiple myeloma and mantle cell lymphoma, both of which are serious hematological malignancies. It works by inhibiting the 26S proteasome, disrupting cancer cell proliferation.

Q: When is it necessary to reconstitute Bortezomib 2.5 Mg before administration?

A: Reconstitution is required immediately prior to each dose. The vial contains a lyophilized powder that must be dissolved using the appropriate solvent right before use, ensuring maximum stability and effectiveness during treatment.

Q: Where can hospitals or clinics source Bortezomib 2.5 Mg?

A: Hospitals, clinics, and authorized distributors can order Bortezomib 2.5 Mg directly from our company, a leading exporter, supplier, trader, and wholesaler based in India. Bulk purchases and express delivery services are available upon request.

Q: What is the typical storage requirement and shelf life for Bortezomib 2.5 Mg?

A: Bortezomib 2.5 Mg should be stored below 30C in its original packaging. The product has a shelf life of up to 2 years if kept under the recommended storage conditions.

Tell us about your requirement